Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ammar Alkrouk
Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Evaluation of theIn VitroActivity of Meropenem-Vaborbactam Against Clinical Isolates of KPC-PositiveEnterobacteriaceae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antimicrobial Activity of Ceftazidime-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Pseudomonas Aeruginosa Isolates From United States Medical Centers (2013--2016)
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Effects of Klebsiella Pneumoniae Carbapenemase Subtypes, Extended-Spectrum Β-Lactamases, and Porin Mutations on theIn VitroActivity of Ceftazidime-Avibactam Against Carbapenem-Resistant K. Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Molecular Epidemiology of Beta-Lactamases in Ceftazidime-Resistant Pseudomonas Aeruginosa Isolates
Mikrobiyoloji Bulteni
Medicine
Infectious Diseases
Immunology
Microbiology
Microbiology
Comparative in Vitro and in Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam Against Pseudomonas Aeruginosa
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
What Is the Role of the New Β-Lactam/Β-Lactamase Inhibitors Ceftolozane/Tazobactam and Ceftazidime/Avibactam?
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
Emergence of Ceftolozane-Tazobactam Resistant Pseudomonas Aeruginosa During Treatment Is Mediated by a Single AmpC Structural Mutation
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
